Palo Alto Investors’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,774,541
Closed -$9.96M 34
2022
Q2
$9.96M Hold
6,774,541
0.87% 19
2022
Q1
$7.79M Buy
6,774,541
+1,289,328
+24% +$1.48M 0.6% 23
2021
Q4
$13.7M Sell
5,485,213
-1,371,300
-20% -$3.43M 0.88% 20
2021
Q3
$35.1M Hold
6,856,513
2.12% 14
2021
Q2
$57M Hold
6,856,513
3.14% 13
2021
Q1
$59.7M Buy
6,856,513
+117,600
+2% +$1.02M 3.4% 11
2020
Q4
$73.2M Buy
6,738,913
+335,313
+5% +$3.64M 3.84% 11
2020
Q3
$76.4M Buy
6,403,600
+889,924
+16% +$10.6M 4.19% 8
2020
Q2
$88.6M Sell
5,513,676
-38,127
-0.7% -$612K 5.32% 8
2020
Q1
$86.1M Sell
5,551,803
-594,142
-10% -$9.22M 7.21% 4
2019
Q4
$151M Sell
6,145,945
-208,714
-3% -$5.13M 8.32% 3
2019
Q3
$65.5M Sell
6,354,659
-580,415
-8% -$5.99M 4.37% 11
2019
Q2
$87M Hold
6,935,074
4.23% 10
2019
Q1
$85.9M Hold
6,935,074
3.58% 13
2018
Q4
$42.7M Buy
6,935,074
+28,916
+0.4% +$178K 2.27% 15
2018
Q3
$73.2M Hold
6,906,158
2.96% 14
2018
Q2
$93.6M Buy
6,906,158
+11,083
+0.2% +$150K 3.74% 11
2018
Q1
$122M Buy
6,895,075
+34,232
+0.5% +$608K 5.23% 8
2017
Q4
$86.1M Buy
6,860,843
+462,547
+7% +$5.8M 3.71% 9
2017
Q3
$122M Buy
6,398,296
+700,000
+12% +$13.3M 5.13% 7
2017
Q2
$86M Buy
5,698,296
+907,245
+19% +$13.7M 4.02% 7
2017
Q1
$82.2M Buy
4,791,051
+1,755,255
+58% +$30.1M 3.88% 8
2016
Q4
$36.7M Buy
3,035,796
+221,256
+8% +$2.68M 2.1% 15
2016
Q3
$27.7M Buy
2,814,540
+103,159
+4% +$1.02M 1.61% 20
2016
Q2
$27.8M Buy
2,711,381
+55,902
+2% +$572K 2.1% 13
2016
Q1
$32.2M Sell
2,655,479
-5,500
-0.2% -$66.7K 2.5% 10
2015
Q4
$42.6M Buy
2,660,979
+545,341
+26% +$8.74M 2.37% 11
2015
Q3
$27.2M Buy
2,115,638
+2,054,373
+3,353% +$26.4M 1.31% 17
2015
Q2
$1.47M Buy
+61,265
New +$1.47M 0.07% 40